Semax Peptide Nasal Spray For Sale

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10) widely investigated for its novel neurotrophic signaling and central nervous system regulatory properties. Laboratory-grade Semax peptide nasal spray solutions provided by PX1 Research are synthesized strictly for in vitro assays, cellular neurobiology models, and preclinical research applications.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10) widely investigated for its novel neurotrophic signaling and central nervous system regulatory properties. Laboratory-grade Semax peptide nasal spray solutions provided by PX1 Research are synthesized strictly for in vitro assays, cellular neurobiology models, and preclinical research applications.

Reviewed by PX1 Research scientific team

Key takeaways

  • Qualified laboratories seeking verified [Semax peptide nasal spray for sale](/product/semax-nasal-spray) require pure, analytical-grade compounds backed by rigorous lot-specific documentation.
  • The molecular architecture of [Semax](/research-peptides/semax) is grounded in the sequence of endogenous ACTH, specifically the heptapeptide fragment corresponding to amino acids 4 through 10 (H-Met-Glu-His-Phe-OH).
  • The primary focus of contemporary [neurological research peptides](/research-peptides/peptides-for-neurological-research) centers on their capacity to modulate neurotrophin expression and intracellular survival cascades.
  • In addition to direct neurotrophic signaling, [Semax](/research-peptides/semax) has been evaluated extensively in preclinical models of focal cerebral ischemia and oxidative stress.

Sourcing Research-Grade Semax Peptide Nasal Spray Formulations

Qualified laboratories seeking verified Semax peptide nasal spray for sale require pure, analytical-grade compounds backed by rigorous lot-specific documentation. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analog of the adrenocorticotropic hormone fragment ACTH(4-10) linked to a C-terminal Pro-Gly-Pro tripeptide sequence. This unique structural modification stabilizes the peptide against rapid enzymatic degradation by circulating peptidases, making it a primary subject of investigation in central nervous system (CNS) regulatory signaling.

When procuring Semax for experimental setups, researchers must distinguish between unverified consumer products and authentic, laboratory-grade reagents. PX1 Research supplies high-purity Semax research peptides engineered specifically for non-human research environments. Every batch undergoes exhaustive analytical validation—including reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS)—to ensure precise molar concentration, sequence integrity, and freedom from synthesis-derived impurities or bacterial contaminants.

Molecular Structure and Derivation of the ACTH(4-10) Analog

The molecular architecture of Semax is grounded in the sequence of endogenous ACTH, specifically the heptapeptide fragment corresponding to amino acids 4 through 10 (H-Met-Glu-His-Phe-OH). While natural ACTH fragments possess inherent neuroactivity, their rapid enzymatic hydrolysis in bio-fluid matrices severely limits their half-life during extended cell culture or tissue slice studies. To circumvent this kinetic bottleneck, molecular researchers integrated a Pro-Gly-Pro carboxyl-terminal tripeptide extension.

This terminal tripeptide modification yields a highly stable heptapeptide structure: Met-Glu-His-Phe-Pro-Gly-Pro. The addition of proline residues induces steric hindrance, significantly impairing the activity of carboxypeptidases and endopeptidases that typically dismantle peptide bonds. In vitro stability assays demonstrate that this structural alteration drastically extends the operational half-life of Semax in biological matrices, permitting extended monitoring of intracellular cascades and receptor-ligand interaction dynamics without premature peptide breakdown.

Preclinical Mechanisms: BDNF Pathway and Neurotrophic Signal Expression

The primary focus of contemporary neurological research peptides centers on their capacity to modulate neurotrophin expression and intracellular survival cascades. Preclinical evidence indicates that Semax rapidly upregulates the transcription and translation of Brain-Derived Neurotrophic Factor (BDNF) and its primary receptor, tropomyosin receptor kinase B (TrkB), in basal forebrain, hippocampal, and cortical tissue models.

In rodent models, acute exposure to Semax has been shown to induce a rapid surge in BDNF mRNA transcripts within 1 to 3 hours following administration. BDNF serves as a critical signaling molecule governing synaptic plasticity, long-term potentiation (LTP), dendritic arborization, and neuronal survival under metabolic or oxidative challenge. Furthermore, in vitro neuronal assays demonstrate that Semax secondary signaling activates downstream extracellular signal-regulated kinase (ERK) and protein kinase B (Akt) pathways. This dual activation supports cellular resilience against glutamate-induced excitotoxicity and ischemic hypoxia.

Cellular Stress Modulation and Cerebrovascular Response Models

In addition to direct neurotrophic signaling, Semax has been evaluated extensively in preclinical models of focal cerebral ischemia and oxidative stress. Laboratory models measuring gene expression profiles during simulated hypoxic-ischemic events demonstrate that Semax influences vast transcriptional networks involved in vascular regulation, inflammatory responses, and apoptotic cascades.

Microarray studies conducted on ischemic rat brain tissue reveal that Semax administration leads to the differential expression of hundreds of genes. Notably, it suppresses genes linked to pro-inflammatory cytokine cascades—such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α)—while simultaneously upregulating trophic factors like Vascular Endothelial Growth Factor (VEGF). This dual mechanism suggests that Semax promotes microvascular stabilization and limits secondary inflammatory damage surrounding necrotic lesion sites in experimental models.

Researchers exploring gene expression patterns can review detailed literature summaries in our dedicated peptides research library, detailing how synthetic regulatory peptides interact with transcriptional machinery during acute cellular stress.

Comparative Analysis: Semax, Selank, and N-Acetyl Derivatives

When designing neurobiology or peptide-stability experiments, researchers frequently compare Semax against related regulatory compounds in the regulatory peptide class. Understanding the biochemical nuances among these research peptides helps investigators select the optimal molecule for specific assay conditions.

A comparison of prominent regulatory research peptides includes:

- Semax Peptide Nasal Spray: An ACTH(4-10) analog focused primarily on BDNF mRNA upregulation, TrkB activation, cholinergic system modulation, and ischemic cellular defense.

- Selank Peptide Nasal Spray: A synthetic derivative of the endogenous immunomodulatory tetrapeptide Tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). Unlike Semax, Selank primarily targets enkephalin degradation pathways, GABAergic neurotransmission, and systemic cytokine balance in stress models.

- N-Acetyl Semax Amidate: A structurally enhanced derivative of Semax featuring N-terminal acetylation and C-terminal amidation. These synthetic caps reduce overall polar surface area, increasing resistance to enzymatic cleavage and altering lipophilicity in membrane permeability assays.

To explore the comparative immunomodulatory and neurotropic profiles of these compounds in detail, consult our technical breakdown on Selank peptide research mechanisms.

Intranasal Delivery Dynamics in Preclinical CNS Assays

The utilization of intranasal formulations in rodent and in vivo non-human models provides a non-invasive pathway for targeting central nervous system structures while bypassing the systemic circulation and hepatic first-pass metabolism. The anatomical architecture of the nasal cavity—specifically the olfactory epithelium and the trigeminal nerve pathway—allows direct transport of low-molecular-weight peptides into the cerebrospinal fluid (CSF) and brain parenchyma.

Preclinical radiolabeling studies demonstrate that intranasally administered Semax rapidly translocates along the olfactory nerve tract, achieving detectable concentrations in the olfactory bulb, hippocampus, and cerebral cortex within minutes. By utilizing standardized intranasal spray delivery devices, laboratory researchers can maintain precise volumetric dosing per actuator, ensuring consistent experimental parameters across longitudinal animal cohorts without the physiological stress associated with repeated parenteral injections.

Quality Verification Standards: HPLC, MS, and Endotoxin Testing

The scientific validity of any preclinical trial hinges upon the chemical purity and consistency of the starting research reagents. PX1 Research adheres to uncompromising quality control protocols to ensure every unit of Semax peptide nasal spray for sale meets stringent analytical specifications.

Our analytical validation protocol includes:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Determines exact chromatographic purity, guaranteeing >99.0% concentration of the active Met-Glu-His-Phe-Pro-Gly-Pro peptide while identifying and excluding truncated sequence artifacts.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular weight (Theoretical Monoisotopic Mass: 873.41 g/mol) to verify sequence accuracy without mass deviation.

3. Bacterial Endotoxin Testing (LAL Assay): Ensures endotoxin levels remain well below standard preclinical safety thresholds (<0.05 EU/mg), preventing confounding pyrogenic or inflammatory responses in tissue culture or animal models.

4. Lot-Specific Certificate of Analysis (COA): Every shipped unit is tied to a publicly accessible COA detailing real-time analytical data generated in ISO 17025 accredited facilities.

Laboratory Handling, Reconstitution, and Storage Protocol

Maintaining peptide integrity requires strict adherence to laboratory storage standards. Semax in intranasal aqueous formulation or lyophilisate form is sensitive to thermal degradation, photo-oxidation, and mechanical shear stress.

Upon receipt at your research facility, lyophilized Semax vials should be stored at -20°C for long-term stability. If working with pre-formulated liquid nasal spray solutions, store the container at 2°C to 8°C (refrigerated) protected from light exposure. Avoid freezing liquid spray containers to prevent structural denaturation of the peptide matrix or mechanical failure of the spray actuator mechanism.

For reconstituted or liquid solutions, handle under aseptic conditions within a laminar flow hood. Utilize sterile lab-grade diluents (such as 0.9% bacteriostatic sodium chloride or sterile phosphate-buffered saline) when diluting concentrated stock vials for custom assay concentrations. For bulk procurement or specialized laboratory supply arrangements, explore our wholesale research lab accounts portal.

Why Institutional Labs Choose PX1 Research

PX1 Research operates as a premier American supplier of high-purity research compounds for academic institutions, biotechnology firms, and private analytical laboratories. All manufacturing is conducted in GMP-compliant, state-of-the-art facilities located within the United States.

When purchasing Semax peptide nasal spray for sale, institutional researchers benefit from fast, reliable fulfillment. Orders placed Monday through Friday ship same-day from our dual distribution centers in California and Arizona. Each order is packed in climate-regulated packaging to guarantee full structural preservation during transport. Investigate our full catalog of high-purity research peptides to support your lab's ongoing neurobiology and molecular signaling projects.

Frequently Asked Questions

What is Semax peptide intended for in scientific research?

Semax is a synthetic heptapeptide ACTH(4-10) analog designated strictly for laboratory research use. Preclinical studies evaluate Semax for its influence on BDNF transcription, TrkB receptor expression, neuroprotective mechanisms during ischemic stress, and cholinergic neurotransmission.

How does Semax differ structurally from natural ACTH?

Semax contains the N-terminal sequence of ACTH(4-10) combined with a C-terminal Pro-Gly-Pro tripeptide. This tripeptide extension protects the molecule from rapid carboxypeptidase cleavage, extending its metabolic stability in experimental biological media.

How is PX1 Research Semax verified for purity and identity?

Every lot of Semax peptide undergoes rigorous independent third-party analysis, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chromatographic purity (>99.0%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify molecular weight. Endotoxin levels are measured via LAL assays.

Can Semax peptide spray be used for human consumption or medical therapy?

No. All products offered by PX1 Research, including Semax peptide nasal spray, are strictly for in vitro, cell culture, and preclinical laboratory research. They are not for human consumption, clinical use, therapy, or diagnostic applications.

What is the recommended storage temperature for liquid Semax nasal spray?

Pre-formulated liquid Semax spray solutions should be kept refrigerated at 2°C to 8°C and protected from light. Lyophilized peptide powders should be stored long-term at -20°C until reconstitution.

What is the molecular weight and chemical formula of Semax?

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) has a molecular formula of C37H51N9O10S and a monoisotopic molecular weight of approximately 873.41 g/mol.

What are the primary target pathways of Semax in rodent models?

In animal models, Semax has been shown to upregulate mRNA expression of BDNF and TrkB receptors, stimulate the ERK and Akt intracellular survival pathways, and suppress pro-inflammatory cytokines like IL-1β during simulated ischemic events.

Does PX1 Research provide bulk or institutional lab pricing for Semax?

Yes. Institutional purchasing agents and principal investigators can request high-volume procurement and dedicated account services through the PX1 Research wholesale portal.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.